A new trading day began on Friday, with Tyra Biosciences Inc (NASDAQ: TYRA) stock price up 2.43% from the previous day of trading, before settling in for the closing price of $12.37. TYRA’s price has ranged from $6.42 to $29.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -73.69% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -33.00%. With a float of $33.77 million, this company’s outstanding shares have now reached $53.23 million.
Tyra Biosciences Inc (TYRA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tyra Biosciences Inc is 36.55%, while institutional ownership is 75.58%. The most recent insider transaction that took place on Jun 18 ’25, was worth 93,596. In this transaction Director of this company sold 9,568 shares at a rate of $9.78, taking the stock ownership to the 28,231 shares. Before that another transaction happened on Jun 17 ’25, when Company’s Director sold 10 for $10.35, making the entire transaction worth $104. This insider now owns 37,799 shares in total.
Tyra Biosciences Inc (TYRA) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.41 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -33.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -17.49% during the next five years compared to -73.69% drop over the previous five years of trading.
Tyra Biosciences Inc (NASDAQ: TYRA) Trading Performance Indicators
Here are Tyra Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 21.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.79, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -2.26 in one year’s time.
Technical Analysis of Tyra Biosciences Inc (TYRA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.24 million. That was inferior than the volume of 0.3 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 85.73%.
During the past 100 days, Tyra Biosciences Inc’s (TYRA) raw stochastic average was set at 92.69%, which indicates a significant increase from 84.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.71 in the past 14 days, which was higher than the 0.71 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.66, while its 200-day Moving Average is $11.84. However, in the short run, Tyra Biosciences Inc’s stock first resistance to watch stands at $12.80. Second resistance stands at $12.93. The third major resistance level sits at $13.17. If the price goes on to break the first support level at $12.44, it is likely to go to the next support level at $12.20. Assuming the price breaks the second support level, the third support level stands at $12.07.
Tyra Biosciences Inc (NASDAQ: TYRA) Key Stats
With a market capitalization of 675.27 million, the company has a total of 53,297K Shares Outstanding. Currently, annual sales are 0 K while annual income is -86,480 K. The company’s previous quarter sales were 0 K while its latest quarter income was -28,100 K.
